Eradicating Disease Through Innovative Molecular Imaging
![Radiochemist in PET Center](https://www.columbiaradiology.org/sites/default/files/styles/cola_media_40_3_1/public/media/images/2022-05/img_5199.jpg?itok=Jt4Xt3xP 40w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_200_3_1/public/media/images/2022-05/img_5199.jpg?itok=iikmD8U2 200w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_260_3_1/public/media/images/2022-05/img_5199.jpg?itok=xf-B9acC 260w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_320_3_1/public/media/images/2022-05/img_5199.jpg?itok=Wz6JLwGC 320w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_400_3_1/public/media/images/2022-05/img_5199.jpg?itok=2Qio8WwI 400w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_520_3_1/public/media/images/2022-05/img_5199.jpg?itok=8ICmLiV6 520w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_640_3_1/public/media/images/2022-05/img_5199.jpg?itok=3QVqagLr 640w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_800_3_1/public/media/images/2022-05/img_5199.jpg?itok=GTgwG-9f 800w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_1040_3_1/public/media/images/2022-05/img_5199.jpg?itok=urj9KNFF 1040w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_1280_3_1/public/media/images/2022-05/img_5199.jpg?itok=ZTOz5UZ5 1280w, https://www.columbiaradiology.org/sites/default/files/styles/cola_media_1600_3_1/public/media/images/2022-05/img_5199.jpg?itok=mSIqpwfA 1600w)
Columbia University PET Center
The Columbia University PET Center empowers scientists and physicians to deploy PET imaging in the treatment of disease by leading in safety, customer service, innovation, education, and efficiency. Our state-of-the-art PET cGMP radiolabeling facility produces over 20 aNDA, IND and preclinical tracers. We are closely aligned with our institutional drug development accelerators and have partnered to build an innovative cross translational rapid first-in-human tracer development pathway to help the drug development process.